COLOMBO NICOLETTA

Scambia, G., Villalobos Valencia, R., Colombo, N., Cibula, D., Leath, C., Bidzinski, M., et al. (2025). Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1408-1416 [10.1200/JCO.24.00933]. Dettaglio

Valenza, C., Nicolò, E., Mongillo, M., Trapani, D., Katrini, J., Boldrini, L., et al. (2025). Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study. THE ONCOLOGIST, 30(7 (July 2025)) [10.1093/oncolo/oyae330]. Dettaglio

Lorusso, D., Colombo, N., Dubot, C., Cáceres, M., Hasegawa, K., Shapira-Frommer, R., et al. (2025). Pembrolizumab plus chemotherapy for advanced and recurrent cervical cancer: final analysis according to bevacizumab use in the randomized KEYNOTE-826 study. ANNALS OF ONCOLOGY, 36(1), 65-75 [10.1016/j.annonc.2024.10.002]. Dettaglio

Liu, J., Colombo, N., Oza, A., Frenel, J., Corr, B., Rubinstein, M., et al. (2025). ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 43(26), 2897-2907 [10.1200/JCO-24-01606]. Dettaglio

Caruso, G., Kumar, A., Langstraat, C., Mcgree, M., Fought, A., Harrington, S., et al. (2025). Racial/ethnic, socioeconomic, and healthcare access disparities in achieving textbook oncologic outcome in advanced ovarian cancer. GYNECOLOGIC ONCOLOGY, 195(April 2025), 106-114 [10.1016/j.ygyno.2025.03.016]. Dettaglio